1
|
Oliveira LR, Trein MR, Assis LR, Rigo GV, Simões LPM, Batista VS, Macedo AJ, Trentin DS, Nascimento-Júnior NM, Tasca T, Regasini LO. Phenolic chalcones as agents against Trichomonas vaginalis. Bioorg Chem 2023; 141:106888. [PMID: 37839143 DOI: 10.1016/j.bioorg.2023.106888] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/27/2022] [Revised: 09/12/2023] [Accepted: 09/25/2023] [Indexed: 10/17/2023]
Abstract
Trichomonas vaginalis, a flagellated and anaerobic protozoan, is a causative agent of trichomoniasis. This disease is among the world's most common non-viral sexually transmitted infection. A single class drug, nitroimidazoles, is currently available for the trichomoniasis treatment. However, resistant isolates have been identified from unsuccessfully treated patients. Thus, there is a great challenge for a discovery of innovative anti-T. vaginalis agents. As part of our ongoing search for antiprotozoal chalcones, we designed and synthesized a series of 21 phenolic chalcones, which were evaluated against T. vaginalis trophozoites. Structure-activity relationship indicated hydroxyl group plays a role key in antiprotozoal activity. 4'-Hydroxychalcone (4HC) was the most active compound (IC50 = 27.5 µM) and selected for detailed bioassays. In vitro and in vivo evaluations demonstrated 4HC was not toxic against human erythrocytes and Galleria mellonella larvae. Trophozoites of T. vaginalis were treated with 4HC and did not present significant reactive oxygen species (ROS) accumulation. However, compound 4HC was able to increase ROS accumulation in neutrophils coincubated with T. vaginalis. qRT-PCR Experiments indicated that 4HC did not affect the expression of pyruvate:ferredoxin oxidoreductase (PFOR) and β-tubulin genes. In silico simulations, using purine nucleoside phosphorylase of T. vaginalis (TvPNP), corroborated 4HC as a promising ligand. Compound 4HC was able to establish interactions with residues D21, G20, M180, R28, R87 and T90 through hydrophobic interactions, π-donor hydrogen bond and hydrogen bonds. Altogether, these results open new avenues for phenolic chalcones to combat trichomoniasis, a parasitic neglected infection.
Collapse
Affiliation(s)
- Lígia R Oliveira
- Institute of Biosciences, Humanities and Exact Sciences (Ibilce), São Paulo State University (Unesp), 15054-000 São José do Rio Preto, SP, Brazil
| | - Márcia R Trein
- Faculty of Pharmacy, Federal University of Rio Grande do Sul, 90610-000 Porto Alegre, RS, Brazil
| | - Letícia R Assis
- Institute of Biosciences, Humanities and Exact Sciences (Ibilce), São Paulo State University (Unesp), 15054-000 São José do Rio Preto, SP, Brazil
| | - Graziela V Rigo
- Faculty of Pharmacy, Federal University of Rio Grande do Sul, 90610-000 Porto Alegre, RS, Brazil
| | - Leonardo P M Simões
- Institute of Chemistry, São Paulo State University (Unesp), Rua Professor Francisco Degni, 55, Jardim Quitandinha, Araraquara 14800-060, SP, Brazil
| | - Victor S Batista
- Institute of Chemistry, São Paulo State University (Unesp), Rua Professor Francisco Degni, 55, Jardim Quitandinha, Araraquara 14800-060, SP, Brazil
| | - Alexandre J Macedo
- Faculty of Pharmacy, Federal University of Rio Grande do Sul, 90610-000 Porto Alegre, RS, Brazil
| | - Danielle S Trentin
- Department of Basic Health Sciences, Federal University of Health Sciences of Porto Alegre, 90050-170 Porto Alegre, RS, Brazil
| | - Nailton M Nascimento-Júnior
- Institute of Chemistry, São Paulo State University (Unesp), Rua Professor Francisco Degni, 55, Jardim Quitandinha, Araraquara 14800-060, SP, Brazil
| | - Tiana Tasca
- Faculty of Pharmacy, Federal University of Rio Grande do Sul, 90610-000 Porto Alegre, RS, Brazil.
| | - Luis O Regasini
- Institute of Biosciences, Humanities and Exact Sciences (Ibilce), São Paulo State University (Unesp), 15054-000 São José do Rio Preto, SP, Brazil.
| |
Collapse
|
2
|
de Giacometi M, Mayer JCP, de Mello AB, Islabão YW, Strothmann AL, da Fonseca RN, Sena-Lopes Â, Dornelles L, Borsuk S, Hübner SDO, Oliveira CB. Activity of compounds derived from benzofuroxan in Trichomonasvaginalis. Exp Parasitol 2023; 253:108601. [PMID: 37625643 DOI: 10.1016/j.exppara.2023.108601] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/19/2023] [Revised: 08/08/2023] [Accepted: 08/19/2023] [Indexed: 08/27/2023]
Abstract
Trichomoniasis is a sexually transmitted infection caused by the protozoan Trichomonas vaginalis. Currently, trichomoniasis is treated with the class of nitroimidazoles, namely, metronidazole; however, resistant isolates and strains have been reported. The compounds derived from benzofuroxan are biologically active heterocycles. This study evaluated the in vitro antiparasitic activity of these compounds in trophozoites of T. vaginalis and determined the mean inhibitory concentration (IC50), minimum inhibitory concentration (MIC), mortality curve, and cytotoxicity. The compounds were named EH1, EH2, EH3, and EA2 and tested in various concentrations: 100 to 15 μM (EH1 and EH2); 100 to 5 μM (EH3); and 100 to 25 μM (EA2), respectively. The greatest efficacy was observed in the highest concentrations in 24 h, with inhibition of approximately 100% of trophozoites. Compounds EH2 and EH3 had the lowest MIC: EH2 (35 μM) and EH3 (45 μM), with IC50 of 11.33 μM and 6.83 μM, respectively. Compound EA2 was effective at the highest concentrations. The activity of the compounds in T. vaginalis started in the first hour of incubation with 90% inhibition; after 12 h, inhibition >95% was observed. Compound EH1 showed the lowest activity, with the highest activity between 12 and 24 h after incubation. These results demonstrate that benzofuroxan derivatives are promising compounds for the in vitro treatment of T. vaginalis.
Collapse
Affiliation(s)
- Marjorie de Giacometi
- Department of Microbiology and Parasitology, Federal University of Pelotas, Pelotas, RS, Brazil
| | - João Cândido Pilar Mayer
- Department of Chemistry, LabSelen-NanoBio, Federal University of Santa Maria, Santa Maria, RS, Brazil
| | - Alexia Brauner de Mello
- Department of Microbiology and Parasitology, Federal University of Pelotas, Pelotas, RS, Brazil
| | - Yan Wahast Islabão
- Department of Microbiology and Parasitology, Federal University of Pelotas, Pelotas, RS, Brazil
| | - Adriane Leites Strothmann
- Center for Technological Development, Biotechnology, Federal University of Pelotas, Pelotas, RS, Brazil
| | | | - Ângela Sena-Lopes
- Center for Technological Development, Biotechnology, Federal University of Pelotas, Pelotas, RS, Brazil
| | - Luciano Dornelles
- Department of Chemistry, LabSelen-NanoBio, Federal University of Santa Maria, Santa Maria, RS, Brazil
| | - Sibele Borsuk
- Center for Technological Development, Biotechnology, Federal University of Pelotas, Pelotas, RS, Brazil
| | | | - Camila Belmonte Oliveira
- Department of Microbiology and Parasitology, Federal University of Pelotas, Pelotas, RS, Brazil.
| |
Collapse
|
3
|
Bisbenzylisoquinolines from Cissampelos pareira L. as antimalarial agents: Molecular docking, pharmacokinetics analysis, and molecular dynamic simulation studies. Comput Biol Chem 2023; 104:107826. [PMID: 36848855 DOI: 10.1016/j.compbiolchem.2023.107826] [Citation(s) in RCA: 7] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2022] [Revised: 02/06/2023] [Accepted: 02/08/2023] [Indexed: 02/14/2023]
Abstract
Malaria is a major global health issue due to the emergence of resistance to most of the available antimalarial drugs. There is an urgent need to discover new antimalarials to tackle the resistance issue. The present study aims to explore the antimalarial potential of chemical constituents reported from Cissampelos pareira L., a medicinal plant traditionally known for treating malaria. Phytochemically, benzylisoquinolines and bisbenzylisoquinolines are the major classes of alkaloids reported from this plant. In silico molecular docking revealed prominent interactions of bisbenzylisoquinolines such as hayatinine and curine with Pfdihydrofolate reductase (-6.983 Kcal/mol and -6.237 Kcal/mol), PfcGMP-dependent protein kinase (-6.652 Kcal/mol and -7.158 Kcal/mol), and Pfprolyl-tRNA synthetase (-7.569 Kcal/mol and -7.122 Kcal/mol). The binding affinity of hayatinine and curine with identified antimalarial targets was further evaluated using MD-simulation analysis. Among the identified antimalarial targets, the RMSD, RMSF, the radius of gyration, and PCA indicated the formation of stable complexes of hayatinine and curine with Pfprolyl-tRNA synthetase. The outcomes of in silico investigation putatively suggested that bisbenzylisoquinolines may act on the translation of the Plasmodium parasite to exhibit antimalarial potency.
Collapse
|
4
|
Barbosa TN, Silva MTDO, Sena-Lopes Â, Kremer FS, Sousa FSS, Seixas FK, Collares TV, de Pereira CMP, Borsuk S. Bioprospection of the trichomonacidal activity of lipid extracts derived from marine macroalgae Gigartina skottsbergii. PLoS One 2023; 18:e0285426. [PMID: 37155662 PMCID: PMC10166524 DOI: 10.1371/journal.pone.0285426] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/18/2022] [Accepted: 04/21/2023] [Indexed: 05/10/2023] Open
Abstract
Algal extracts are sources of bioactive substances with applications in the development of novel alternative drugs against several diseases, including trichomoniasis sexually transmitted infection caused by Trichomonas vaginalis. Factors such as clinical failures and resistant strains limit the success of the existing drugs available for treating this disease. Therefore, searching for viable alternatives to these drugs is essential for the treatment of this disease. The present study was conducted for, in vitro and in silico characterization of extracts obtained from marine macroalgae Gigartina skottsbergii at stages gametophidic, cystocarpic, and tetrasporophidic. In addition, antiparasitic activity of these extracts against the ATCC 30236 isolate of T. vaginalis, their cytotoxicity, and gene expression of trophozoites after treatment were evaluated. The minimum inhibitory concentration and 50% inhibition concentration were determined for each extract. Results: In vitro analysis of the extracts' anti-T. vaginalis activity revealed an inhibitory effect of 100%, 89.61%, and 86.95% for Gigartina skottsbergii at stages gametophidic, cystocarpic, and tetrasporophidic, respectively, at 100 μg/mL. In silico analysis revealed the interactions between constituents of the extracts and enzymes from T. vaginalis, with significant free energy values obtained for the binding. None of the extract concentrations exhibited cytotoxic effects on VERO cell line compared to control, while cytotoxicity on HMVII vaginal epithelial cells line was observed at 100 μg/mL (30% inhibition). Gene expression analysis revealed differences in the expression profile of T. vaginalis enzymes between the extract-treated and control groups. According to these results, Gigartina skottsbergii extracts exhibited satisfactory antiparasitic activity.
Collapse
Affiliation(s)
- Tallyson Nogueira Barbosa
- Laboratório de Biotecnologia Infecto-Parasitária, Centro de Desenvolvimento Tecnológico, Biotecnologia, UFPel, Pelotas, Rio Grande do Sul, Brasil
| | - Mara Thais de Oliveira Silva
- Laboratório de Biotecnologia Infecto-Parasitária, Centro de Desenvolvimento Tecnológico, Biotecnologia, UFPel, Pelotas, Rio Grande do Sul, Brasil
| | - Ângela Sena-Lopes
- Laboratório de Biotecnologia Infecto-Parasitária, Centro de Desenvolvimento Tecnológico, Biotecnologia, UFPel, Pelotas, Rio Grande do Sul, Brasil
| | - Frederico Schmitt Kremer
- Laboratório de Lipidômica e Bio-orgânica, Centro de Ciências Químicas, Farmacêuticas e de Alimentos, UFPel, Pelotas, Rio Grande do Sul, Brasil
| | - Fernanda Severo Sabedra Sousa
- Laboratório de Bioinformática e Proteômica, Centro de Desenvolvimento Tecnológico, Biotecnologia, UFPel, Pelotas, Rio Grande do Sul, Brasil
| | - Fabiana Kommling Seixas
- Laboratório de Bioinformática e Proteômica, Centro de Desenvolvimento Tecnológico, Biotecnologia, UFPel, Pelotas, Rio Grande do Sul, Brasil
| | - Tiago Veiras Collares
- Laboratório de Bioinformática e Proteômica, Centro de Desenvolvimento Tecnológico, Biotecnologia, UFPel, Pelotas, Rio Grande do Sul, Brasil
| | - Cláudio Martin Pereira de Pereira
- Laboratório de Biotecnologia do Câncer, Centro de Desenvolvimento Tecnológico, Biotecnologia, UFPel, Pelotas, Rio Grande do Sul, Brasil
| | - Sibele Borsuk
- Laboratório de Biotecnologia Infecto-Parasitária, Centro de Desenvolvimento Tecnológico, Biotecnologia, UFPel, Pelotas, Rio Grande do Sul, Brasil
| |
Collapse
|
5
|
Chuong Nguyen TH, Kim Lien GT, Yen PH, Ho TT, Thuy Van DT, Van Kiem P, Hung NH, Kuo PC, Setzer WN. Molluscicidal Activity of Compounds From the Roots of Aralia armata Against the Golden Apple Snail ( Pomacea canaliculata). Nat Prod Commun 2022. [DOI: 10.1177/1934578x221144573] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022] Open
Abstract
Background: Aralia armata (Araliaceae) is considered to exhibit effective molluscicidal activity, however, the relationship between the chemical components and molluscicidal activity has not been clearly elucidated. This research attempts to decipher these correlations among the 15 compounds isolated from Vietnam-grown A. armata roots against the freshwater snail, Pomacea canaliculata, a gastropod causing severe damage in agricultural production. Methods: Fifteen saponins were isolated from the methanol root extract of A. armata using chromatographic methods and were identified using spectroscopic techniques. The compounds were screened for molluscicidal activity against P. canaliculata, as well as toxicity against brine shrimp ( Artemia sp.) and phytotoxicity against rice germination and growth. Results: The saponin compounds exhibited extraordinary inhibition of P. canaliculata with LC50 values ranging from 7.90 to 17.50 µg/mL. Notably, the active compounds from A. armata exhibit safety for both nontarget aquatic animals, specifically Artemia sp. with LC50 values between 148.55 and 193.22 µg/mL, and the growth and development of Oryza sativa L. plants showed very little difference compared with the negative control . A molecular docking analysis indicated P. canaliculata acetylcholinesterase (PcAChE) and the actin-binding protein villin (PcVillin) to be potential biomolecular targets of the A. armata saponins. Conclusion: The present experimental and in silico data illustrate the potential of A. armata in agricultural applications.
Collapse
Affiliation(s)
- Thi Hong Chuong Nguyen
- Institute of Research and Development, Duy Tan University, Danang, Vietnam
- Faculty of Natural sciences, Duy Tan University, Danang, Vietnam
| | - Giang Thi Kim Lien
- Institute for Research and Executive Education, The University of Danang, Danang, Vietnam
| | - Pham Hai Yen
- Institute of Marine Biochemistry, Vietnam Academy of Science and Technology (VAST), Cau Giay, Hanoi, Vietnam
| | - Thanh-Tam Ho
- Faculty of Natural sciences, Duy Tan University, Danang, Vietnam
- Institute for Global Health Innovations, Duy Tan University, Danang, Vietnam
| | - Do Thi Thuy Van
- University of Science Education, The University of Danang, Danang, Vietnam
| | - Phan Van Kiem
- Institute of Marine Biochemistry, Vietnam Academy of Science and Technology (VAST), Cau Giay, Hanoi, Vietnam
| | - Nguyen Huy Hung
- Institute of Research and Development, Duy Tan University, Danang, Vietnam
- Faculty of Natural sciences, Duy Tan University, Danang, Vietnam
| | - Ping-Chung Kuo
- School of Pharmacy, College of Medicine, National Cheng Kung University, Tainan
| | - William N. Setzer
- Department of Chemistry, University of Alabama in Huntsville, Huntsville, AL, USA
| |
Collapse
|
6
|
Chemical Composition and In Vitro and In Silico Antileishmanial Evaluation of the Essential Oil from Croton linearis Jacq. Stems. Antibiotics (Basel) 2022; 11:antibiotics11121712. [PMID: 36551370 PMCID: PMC9774621 DOI: 10.3390/antibiotics11121712] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/01/2022] [Revised: 11/23/2022] [Accepted: 11/24/2022] [Indexed: 11/29/2022] Open
Abstract
Croton linearis Jacq. is an aromatic shrub that has been utilized in traditional medicine in the Bahamas, Jamaica, and Cuba. Recent studies have revealed the antiprotozoal potential of its leaves. The present work is aimed to identify the volatile constituents of essential oil from the stems of C. linearis (CLS-EO) and evaluate its in vitro antileishmanial activity. In addition, an in silico study of the molecular interactions was performed using molecular docking. A gas chromatographic-mass spectrometric analysis of CLS-EO identified 1,8-cineole (27.8%), α-pinene (11.1%), cis-sabinene (8.1%), p-cymene (5.7%), α-terpineol (4.4%), epi-γ-eudesmol (4.2%), linalool (3.9%), and terpinen-4-ol (2.6%) as major constituents. The evaluation of antileishmanial activity showed that CLS-EO has good activity on both parasite forms (IC50Promastigote = 21.4 ± 0.1 μg/mL; IC50Amastigote = 18.9 ± 0.3 μg/mL), with a CC50 of 49.0 ± 5.0 μg/mL on peritoneal macrophages from BALB/c mice (selectivity index = 2 and 3 using the promastigote and amastigote results). Molecular docking showed good binding of epi-γ-eudesmol with different target enzymes of Leishmania. This study is the first report of the chemical composition and anti-Leishmania evaluation of CLS-EO. These findings provide support for further studies of the antileishmanial effect of this product.
Collapse
|
7
|
Alves MSD, Sena-Lopes Â, das Neves RN, Casaril AM, Domingues M, Birmann PT, da Silva ET, de Souza MVN, Savegnago L, Borsuk S. In vitro and in silico trichomonacidal activity of 2,8-bis(trifluoromethyl) quinoline analogs against Trichomonas vaginalis. Parasitol Res 2022; 121:2697-2711. [PMID: 35857093 DOI: 10.1007/s00436-022-07598-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2022] [Accepted: 07/09/2022] [Indexed: 11/29/2022]
Abstract
Trichomoniasis is a great public health burden worldwide and the increase in treatment failures has led to a need for finding alternative molecules to treat this disease. In this study, we present in vitro and in silico analyses of two 2,8-bis(trifluoromethyl) quinolines (QDA-1 and QDA-2) against Trichomonas vaginalis. For in vitro trichomonacidal activity, up to seven different concentrations of these drugs were tested. Molecular docking, biochemical, and cytotoxicity analyses were performed to evaluate the selectivity profile. QDA-1 displayed a significant effect, completely reducing trophozoites viability at 160 µM, with an IC50 of 113.8 µM, while QDA-2 at the highest concentration reduced viability by 76.9%. QDA-1 completely inhibited T. vaginalis growth and increased reactive oxygen species production and lipid peroxidation after 24 h of treatment, but nitric oxide accumulation was not observed. In addition, molecular docking studies showed that QDA-1 has a favorable binding mode in the active site of the T. vaginalis enzymes purine nucleoside phosphorylase, lactate dehydrogenase, triosephosphate isomerase, and thioredoxin reductase. Moreover, QDA-1 presented a level of cytotoxicity by reducing 36.7% of Vero cells' viability at 200 µM with a CC50 of 247.4 µM and a modest selectivity index. In summary, the results revealed that QDA-1 had a significant anti-T. vaginalis activity. Although QDA-1 had detectable cytotoxicity, the concentration needed to eliminate T. vaginalis trophozoites is lower than the CC50 encouraging further studies of this compound as a trichomonacidal agent.
Collapse
Affiliation(s)
- Mirna Samara Dié Alves
- Laboratório de Biotecnologia Infecto-Parasitária, Centro de Desenvolvimento Tecnológico, Biotecnologia, Universidade Federal de Pelotas, Pelotas, RS, 96010-900, Brazil
| | - Ângela Sena-Lopes
- Laboratório de Biotecnologia Infecto-Parasitária, Centro de Desenvolvimento Tecnológico, Biotecnologia, Universidade Federal de Pelotas, Pelotas, RS, 96010-900, Brazil
| | - Raquel Nascimento das Neves
- Laboratório de Biotecnologia Infecto-Parasitária, Centro de Desenvolvimento Tecnológico, Biotecnologia, Universidade Federal de Pelotas, Pelotas, RS, 96010-900, Brazil
| | - Angela Maria Casaril
- Laboratório de Neurobiotecnologia, Centro de Desenvolvimento Tecnológico, Biotecnologia, Universidade Federal de Pelotas, Pelotas, RS, 96010-900, Brazil
| | - Micaela Domingues
- Laboratório de Neurobiotecnologia, Centro de Desenvolvimento Tecnológico, Biotecnologia, Universidade Federal de Pelotas, Pelotas, RS, 96010-900, Brazil
| | - Paloma Taborda Birmann
- Laboratório de Neurobiotecnologia, Centro de Desenvolvimento Tecnológico, Biotecnologia, Universidade Federal de Pelotas, Pelotas, RS, 96010-900, Brazil
| | - Emerson Teixeira da Silva
- Instituto de Tecnologia em Fármacos - Far-Manguinhos, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, RJ, 21041-250, Brazil
| | - Marcus Vinicius Nora de Souza
- Instituto de Tecnologia em Fármacos - Far-Manguinhos, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, RJ, 21041-250, Brazil.,Programa de Pós-Graduação em Química, Instituto de Química, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, 21945-970, Brazil
| | - Lucielli Savegnago
- Laboratório de Neurobiotecnologia, Centro de Desenvolvimento Tecnológico, Biotecnologia, Universidade Federal de Pelotas, Pelotas, RS, 96010-900, Brazil
| | - Sibele Borsuk
- Laboratório de Biotecnologia Infecto-Parasitária, Centro de Desenvolvimento Tecnológico, Biotecnologia, Universidade Federal de Pelotas, Pelotas, RS, 96010-900, Brazil.
| |
Collapse
|
8
|
Lactate dehydrogenase and malate dehydrogenase: Potential antiparasitic targets for drug development studies. Bioorg Med Chem 2021; 50:116458. [PMID: 34687983 DOI: 10.1016/j.bmc.2021.116458] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/15/2021] [Revised: 09/27/2021] [Accepted: 10/05/2021] [Indexed: 12/24/2022]
Abstract
Parasitic diseases remain a major public health concern for humans, claiming millions of lives annually. Although different treatments are required for these diseases, drug usage is limited due to the development of resistance and toxicity, which necessitate alternative therapies. It has been shown in the literature that parasitic lactate dehydrogenases (LDH) and malate dehydrogenases (MDH) have unique pharmacological selective and specificity properties compared to other isoforms, thus highlighting them as viable therapeutic targets involved in aerobic and anaerobic glycolytic pathways. LDH and MDH are important therapeutic targets for invasive parasites because they play a critical role in the progression and development of parasitic diseases. Any strategy to impede these enzymes would be fatal to the parasites, paving the way to develop and discover novel antiparasitic agents. This review aims to highlight the importance of parasitic LDH and MDH as therapeutic drug targets in selected obligate apicoplast parasites. To the best of our knowledge, this review presents the first comprehensive review of LDH and MDH as potential antiparasitic targets for drug development studies.
Collapse
|
9
|
Vázquez-Jiménez LK, Moreno-Herrera A, Juárez-Saldivar A, González-González A, Ortiz-Pérez E, Paz-González AD, Palos-Pizarro I, Ramírez-Moreno E, Rivera G. Recent Advances in the Development of Triose Phosphate Isomerase Inhibitors as Antiprotozoal Agents. Curr Med Chem 2021; 29:2504-2529. [PMID: 34517794 DOI: 10.2174/0929867328666210913090928] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/19/2021] [Revised: 07/10/2021] [Accepted: 07/20/2021] [Indexed: 11/22/2022]
Abstract
BACKGROUND Parasitic diseases caused by protozoa such as Chagas disease, leishmaniasis, malaria, African trypanosomiasis, amebiasis, trichomoniasis, and giardiasis are considered serious public health problems in developing countries. Drug-resistance among parasites justifies the search for new therapeutic drugs and the identification of new targets becomes a valuable approach. In this scenario, glycolysis pathway which consists of the conversion of glucose into pyruvate plays an important role in the protozoa energy supply and it is therefore considered as a promising target. In this pathway, triose phosphate isomerase (TIM) plays an essential role in efficient energy production. Furthermore, protozoa TIM show structural differences with human enzyme counterparts suggesting the possibility of obtaining selective inhibitors. Therefore, TIM is considered a valid approach to develop new antiprotozoal agents, inhibiting the glycolysis in the parasite. OBJECTIVE In this review, we discuss the drug design strategies, structure-activity relationship, and binding modes of outstanding TIM inhibitors against Trypanosoma cruzi, Trypanosoma brucei, Plasmodium falciparum, Giardia lamblia, Leishmania mexicana, Trichomonas vaginalis, and Entamoeba histolytica. RESULTS TIM inhibitors showed mainly aromatic systems and symmetrical structure, where the size and type of heteroatom are important for enzyme inhibition. This inhibition is mainly based on the interaction with i) the interfacial region of TIM inducing changes on the quaternary and tertiary structure or ii) with the TIM catalytic region were the main pathways that disabled the catalytic activity of the enzyme. CONCLUSION Benzothiazole, benzoxazole, benzimidazole, and sulfhydryl derivatives stand out as TIM inhibitors. In silico and in vitro studies demonstrate that the inhibitors bind mainly at the TIM dimer interface. In this review, the development of new TIM inhibitors as antiprotozoal drugs is demonstrated as an important pharmaceutical strategy that may lead to new therapies for these ancient parasitic diseases.
Collapse
Affiliation(s)
- Lenci K Vázquez-Jiménez
- Laboratorio de Biotecnología Farmacéutica, Centro de Biotecnología Genómica, Instituto Politécnico Nacional, 88710 Reynosa. Mexico
| | - Antonio Moreno-Herrera
- Laboratorio de Biotecnología Farmacéutica, Centro de Biotecnología Genómica, Instituto Politécnico Nacional, 88710 Reynosa. Mexico
| | - Alfredo Juárez-Saldivar
- Laboratorio de Biotecnología Farmacéutica, Centro de Biotecnología Genómica, Instituto Politécnico Nacional, 88710 Reynosa. Mexico
| | - Alonzo González-González
- Laboratorio de Biotecnología Farmacéutica, Centro de Biotecnología Genómica, Instituto Politécnico Nacional, 88710 Reynosa. Mexico
| | - Eyra Ortiz-Pérez
- Laboratorio de Biotecnología Farmacéutica, Centro de Biotecnología Genómica, Instituto Politécnico Nacional, 88710 Reynosa. Mexico
| | - Alma D Paz-González
- Laboratorio de Biotecnología Farmacéutica, Centro de Biotecnología Genómica, Instituto Politécnico Nacional, 88710 Reynosa. Mexico
| | - Isidro Palos-Pizarro
- Unidad Académica Multidisciplinaria Reynosa-Rodhe, Universidad Autónoma de Tamaulipas, 88779 Reynosa. Mexico
| | - Esther Ramírez-Moreno
- Escuela Nacional de Medicina y Homeopatía, Instituto Politécnico Nacional, 07320 Ciudad de México. Mexico
| | - Gildardo Rivera
- Laboratorio de Biotecnología Farmacéutica, Centro de Biotecnología Genómica, Instituto Politécnico Nacional, 88710 Reynosa. Mexico
| |
Collapse
|
10
|
Rosca AS, Castro J, Sousa LGV, Cerca N. Gardnerella and vaginal health: the truth is out there. FEMS Microbiol Rev 2020; 44:73-105. [PMID: 31697363 DOI: 10.1093/femsre/fuz027] [Citation(s) in RCA: 40] [Impact Index Per Article: 10.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/07/2019] [Accepted: 11/06/2019] [Indexed: 12/16/2022] Open
Abstract
The human vagina is a dynamic ecosystem in which homeostasis depends on mutually beneficial interactions between the host and their microorganisms. However, the vaginal ecosystem can be thrown off balance by a wide variety of factors. Bacterial vaginosis (BV) is the most common vaginal infection in women of childbearing age but its etiology is not yet fully understood, with different controversial theories being raised over the years. What is generally accepted is that BV is often characterized by a shift in the composition of the normal vaginal microbiota, from a Lactobacillus species dominated microbiota to a mixture of anaerobic and facultative anaerobic bacteria. During BV, a polymicrobial biofilm develops in the vaginal microenvironment, being mainly composed of Gardnerella species. The interactions between vaginal microorganisms are thought to play a pivotal role in the shift from health to disease and might also increase the risk of sexually transmitted infections acquisition. Here, we review the current knowledge regarding the specific interactions that occur in the vaginal niche and discuss mechanisms by which these interactions might be mediated. Furthermore, we discuss the importance of novel strategies to fight chronic vaginal infections.
Collapse
Affiliation(s)
- Aliona S Rosca
- Centre of Biological Engineering (CEB), Laboratory of Research in Biofilms Rosário Oliveira (LIBRO), University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal
| | - Joana Castro
- Centre of Biological Engineering (CEB), Laboratory of Research in Biofilms Rosário Oliveira (LIBRO), University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal
| | - Lúcia G V Sousa
- Centre of Biological Engineering (CEB), Laboratory of Research in Biofilms Rosário Oliveira (LIBRO), University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal
| | - Nuno Cerca
- Centre of Biological Engineering (CEB), Laboratory of Research in Biofilms Rosário Oliveira (LIBRO), University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal
| |
Collapse
|
11
|
Erridge S, Mangal N, Salazar O, Pacchetti B, Sodergren MH. Cannflavins - From plant to patient: A scoping review. Fitoterapia 2020; 146:104712. [PMID: 32858172 DOI: 10.1016/j.fitote.2020.104712] [Citation(s) in RCA: 17] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/19/2020] [Revised: 08/21/2020] [Accepted: 08/21/2020] [Indexed: 02/09/2023]
Abstract
INTRODUCTION Cannflavins are a group of prenylflavonoids derived from Cannabis sativa L.. Cannflavin A (CFL-A), B (CFL-B) and C (CFL-C) have been heralded for their anti-inflammatory properties in pre-clinical evaluations. This scoping review aims to synthesise the evidence base on cannflavins to provide an overview of the current research landscape to inform research strategies to aid clinical translation. METHODS A scoping review was conducted of EMBASE, MEDLINE, Pubmed, CENTRAL and Google Scholar databases up to 26th February 2020. All studies describing original research on cannflavins and their isomers were included for review. RESULTS 26 full text articles were included. CFL-A and CFL-B demonstrated potent anti-inflammatory activity via inhibition of 12-o-tetradecanoylphorbol 13-acetate induced PGE2 release (CFL-A half maximal inhibitory concentration (IC50): 0.7 μM; CFL-B IC50: 0.7 μM) and microsomal prostaglandin E synthase-1 (CFL-A IC50: 1.8 μM; CFL-B IC50: 3.7 μM). Outcomes were also described in preclinical models of anti-oxidation (CFL-A), anti-parasitic activity (CFL-A, CFL-C), neuroprotection (CFL-A) and cancer (Isocannflavin B, a CFL-B isomer). In-silico screening identified that CFL-A has binding affinity with viral proteins that warrant further investigation. CONCLUSIONS Cannflavins demonstrate a number of promising therapeutic properties, most notably as an anti-inflammatory agent. Low yields of extraction however have previously limited research to small pre-clinical investigations. Identification of cannflavin-rich chemovars, novel extraction techniques and recent identification of a biosynthetic pathway will hopefully allow research to be scaled appropriately. In order to fully evaluate the therapeutic properties of cannflavins focused research now needs to be embedded within institutions with a track-record of clinical translation.
Collapse
Affiliation(s)
- Simon Erridge
- Department of Surgery and Cancer, Imperial College London, UK
| | - Nagina Mangal
- Department of Surgery and Cancer, Imperial College London, UK
| | - Oliver Salazar
- Department of Surgery and Cancer, Imperial College London, UK
| | | | - Mikael H Sodergren
- Department of Surgery and Cancer, Imperial College London, UK; Emmac Life Sciences, London, UK.
| |
Collapse
|
12
|
da Silva JKR, Figueiredo PLB, Byler KG, Setzer WN. Essential Oils as Antiviral Agents. Potential of Essential Oils to Treat SARS-CoV-2 Infection: An In-Silico Investigation. Int J Mol Sci 2020; 21:E3426. [PMID: 32408699 PMCID: PMC7279430 DOI: 10.3390/ijms21103426] [Citation(s) in RCA: 128] [Impact Index Per Article: 32.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2020] [Revised: 05/07/2020] [Accepted: 05/08/2020] [Indexed: 01/08/2023] Open
Abstract
Essential oils have shown promise as antiviral agents against several pathogenic viruses. In this work we hypothesized that essential oil components may interact with key protein targets of the 2019 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). A molecular docking analysis was carried out using 171 essential oil components with SARS-CoV-2 main protease (SARS-CoV-2 Mpro), SARS-CoV-2 endoribonucleoase (SARS-CoV-2 Nsp15/NendoU), SARS-CoV-2 ADP-ribose-1″-phosphatase (SARS-CoV-2 ADRP), SARS-CoV-2 RNA-dependent RNA polymerase (SARS-CoV-2 RdRp), the binding domain of the SARS-CoV-2 spike protein (SARS-CoV-2 rS), and human angiotensin-converting enzyme (hACE2). The compound with the best normalized docking score to SARS-CoV-2 Mpro was the sesquiterpene hydrocarbon (E)-β-farnesene. The best docking ligands for SARS-CoV Nsp15/NendoU were (E,E)-α-farnesene, (E)-β-farnesene, and (E,E)-farnesol. (E,E)-Farnesol showed the most exothermic docking to SARS-CoV-2 ADRP. Unfortunately, the docking energies of (E,E)-α-farnesene, (E)-β-farnesene, and (E,E)-farnesol with SARS-CoV-2 targets were relatively weak compared to docking energies with other proteins and are, therefore, unlikely to interact with the virus targets. However, essential oil components may act synergistically, essential oils may potentiate other antiviral agents, or they may provide some relief of COVID-19 symptoms.
Collapse
Affiliation(s)
- Joyce Kelly R. da Silva
- Laboratório de Biotecnologia de Enzimas e Biotransformações, Universidade Federal do Pará, Belém PA 66075-900, Brazil;
| | - Pablo Luis Baia Figueiredo
- Departamento de Ciências Naturais, Centro de Ciências Sociais e Educação, Universidade do Estado do Pará, Belém PA 66050-540, Brazil;
| | - Kendall G. Byler
- Department of Biological Sciences, University of Alabama in Huntsville, Huntsville, AL 35899, USA;
| | - William N. Setzer
- Department of Chemistry, University of Alabama in Huntsville, Huntsville, AL 35899, USA
- Aromatic Plant Research Center, 230 N 1200 E, Suite 100, Lehi, UT 84043, USA
| |
Collapse
|
13
|
Alves MSD, das Neves RN, Sena-Lopes Â, Domingues M, Casaril AM, Segatto NV, Nogueira TCM, de Souza MVN, Savegnago L, Seixas FK, Collares T, Borsuk S. Antiparasitic activity of furanyl N-acylhydrazone derivatives against Trichomonas vaginalis: in vitro and in silico analyses. Parasit Vectors 2020; 13:59. [PMID: 32046788 PMCID: PMC7014680 DOI: 10.1186/s13071-020-3923-8] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/19/2019] [Accepted: 02/01/2020] [Indexed: 01/08/2023] Open
Abstract
Background Trichomonas vaginalis is the causative agent of trichomoniasis, which is one of the most common sexually transmitted diseases worldwide. Trichomoniasis has a high incidence and prevalence and is associated with serious complications such as HIV transmission and acquisition, pelvic inflammatory disease and preterm birth. Although trichomoniasis is treated with oral metronidazole (MTZ), the number of strains resistant to this drug is increasing (2.5–9.6%), leading to treatment failure. Therefore, there is an urgent need to find alternative drugs to combat this disease. Methods Herein, we report the in vitro and in silico analysis of 12 furanyl N-acylhydrazone derivatives (PFUR 4, a-k) against Trichomonas vaginalis. Trichomonas vaginalis ATCC 30236 isolate was treated with seven concentrations of these compounds to determine the minimum inhibitory concentration (MIC) and 50% inhibitory concentration (IC50). In addition, compounds that displayed anti-T. vaginalis activity were analyzed using thiobarbituric acid reactive substances (TBARS) assay and molecular docking. Cytotoxicity analysis was also performed in CHO-K1 cells. Results The compounds PFUR 4a and 4b, at 6.25 µM, induced complete parasite death after 24 h of exposure with IC50 of 1.69 µM and 1.98 µM, respectively. The results showed that lipid peroxidation is not involved in parasite death. Molecular docking studies predicted strong interactions of PFUR 4a and 4b with T. vaginalis enzymes, purine nucleoside phosphorylase, and lactate dehydrogenase, while only PFUR 4b interacted in silico with thioredoxin reductase and methionine gamma-lyase. PFUR 4a and 4b led to a growth inhibition (< 20%) in CHO-K1 cells that was comparable to the drug of choice, with a promising selectivity index (> 7.4). Conclusions Our results showed that PFUR 4a and 4b are promising molecules that can be used for the development of new trichomonacidal agents for T. vaginalis.![]()
Collapse
Affiliation(s)
- Mirna Samara Dié Alves
- Laboratório de Biotecnologia Infecto-parasitária, Centro de Desenvolvimento Tecnológico, Biotecnologia, UFPel, Pelotas, RS, 96010-900, Brazil
| | - Raquel Nascimento das Neves
- Laboratório de Biotecnologia Infecto-parasitária, Centro de Desenvolvimento Tecnológico, Biotecnologia, UFPel, Pelotas, RS, 96010-900, Brazil
| | - Ângela Sena-Lopes
- Laboratório de Biotecnologia Infecto-parasitária, Centro de Desenvolvimento Tecnológico, Biotecnologia, UFPel, Pelotas, RS, 96010-900, Brazil
| | - Micaela Domingues
- Laboratório de Neurobiotecnologia, Centro de Desenvolvimento Tecnológico, Biotecnologia, UFPel, Pelotas, RS, 96010-900, Brazil
| | - Angela Maria Casaril
- Laboratório de Neurobiotecnologia, Centro de Desenvolvimento Tecnológico, Biotecnologia, UFPel, Pelotas, RS, 96010-900, Brazil
| | - Natália Vieira Segatto
- Laboratório de Biotecnologia do Câncer, Centro de Desenvolvimento Tecnológico, Biotecnologia, UFPel, Pelotas, RS, 96010-900, Brazil
| | | | - Marcus Vinicius Nora de Souza
- Instituto de Tecnologia em Fármacos-Far-Manguinhos, Fiocruz-Fundação Oswaldo Cruz, Rio de Janeiro, RJ, 21041-250, Brazil.,Programa de Pós-Graduação em Química, Instituto de Química, Universidade Federal do Rio de Janeiro, Cidade Universitária, Rio de Janeiro, RJ, 21945-970, Brazil
| | - Lucielli Savegnago
- Laboratório de Neurobiotecnologia, Centro de Desenvolvimento Tecnológico, Biotecnologia, UFPel, Pelotas, RS, 96010-900, Brazil
| | - Fabiana Kömmling Seixas
- Laboratório de Biotecnologia do Câncer, Centro de Desenvolvimento Tecnológico, Biotecnologia, UFPel, Pelotas, RS, 96010-900, Brazil
| | - Tiago Collares
- Laboratório de Biotecnologia do Câncer, Centro de Desenvolvimento Tecnológico, Biotecnologia, UFPel, Pelotas, RS, 96010-900, Brazil
| | - Sibele Borsuk
- Laboratório de Biotecnologia Infecto-parasitária, Centro de Desenvolvimento Tecnológico, Biotecnologia, UFPel, Pelotas, RS, 96010-900, Brazil.
| |
Collapse
|
14
|
das Neves RN, Sena-Lopes Â, Alves MSD, da Rocha Fonseca B, da Silva CC, Casaril AM, Savegnago L, de Pereira CMP, Ramos DF, Borsuk S. 2'-Hydroxychalcones as an alternative treatment for trichomoniasis in association with metronidazole. Parasitol Res 2019; 119:725-736. [PMID: 31853622 DOI: 10.1007/s00436-019-06568-4] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/22/2019] [Accepted: 11/26/2019] [Indexed: 12/01/2022]
Abstract
The treatment for trichomoniasis, based on 5'-nitroimidazol agents, has been presenting failures related to allergic reactions, side effects, and the emergence of resistant isolates. There are no alternative drugs approved for the treatment of these cases; thus, the search for new active molecules is necessary. In this scenario, chalcones have been extensively studied for their promising biological activities. Here, we presented the synthesis of three hydroxychalcones (3a, b, and c), in vitro and in silico analyses against Trichomonas vaginalis. The in vitro biological evaluation showed that hydroxychalcone 3c presented anti-T. vaginalis activity, with complete death in 12 h of incubation at minimum inhibitory concentration (MIC) of 100 μM. 3c showed a dose-dependent cytotoxicity against mammalian VERO cell line, but the association of 3c at 12.5 μM and metronidazole (MTZ) at 40 μM showed 95.31% activity against T. vaginalis trophozoites after 24 h of exposure and did not affect the VERO cell growth, appearing to be a good alternative. In silico analysis by molecular docking showed that 3c could inhibit the activity of TvMGL (methionine gamma-lyase), TvLDH (lactate dehydrogenase), and TvPNP (purine nucleoside phosphorylase) affecting the T. vaginalis survival and also suggesting a different mechanism of action from MTZ. Therefore, these results propose that hydroxychalcones are promising anti-T. vaginalis agents and must be considered for further investigations regarding trichomoniasis treatment.
Collapse
Affiliation(s)
- Raquel Nascimento das Neves
- Laboratório de Biotecnologia Infecto-parasitária, Centro de Desenvolvimento Tecnológico, Biotecnologia, UFPel, Campus Universitário s/n, Prédio 19 -, Pelotas, RS, 96010-900, Brazil
| | - Ângela Sena-Lopes
- Laboratório de Biotecnologia Infecto-parasitária, Centro de Desenvolvimento Tecnológico, Biotecnologia, UFPel, Campus Universitário s/n, Prédio 19 -, Pelotas, RS, 96010-900, Brazil
| | - Mirna Samara Dié Alves
- Laboratório de Biotecnologia Infecto-parasitária, Centro de Desenvolvimento Tecnológico, Biotecnologia, UFPel, Campus Universitário s/n, Prédio 19 -, Pelotas, RS, 96010-900, Brazil
| | - Bárbara da Rocha Fonseca
- Laboratório de Biotecnologia Infecto-parasitária, Centro de Desenvolvimento Tecnológico, Biotecnologia, UFPel, Campus Universitário s/n, Prédio 19 -, Pelotas, RS, 96010-900, Brazil
| | - Caroline Carapina da Silva
- Laboratório de Lipidômica e Bio-orgânicass, Grupo de Ciências Químicas Farmacêuticas e de Alimentos, UFPel, Pelotas, RS, Brazil
| | - Angela Maria Casaril
- Laboratório de Neurobiotecnologia, Centro de Desenvolvimento Tecnológico, Biotecnologia, UFPel, Pelotas, RS, Brazil
| | - Lucielli Savegnago
- Laboratório de Neurobiotecnologia, Centro de Desenvolvimento Tecnológico, Biotecnologia, UFPel, Pelotas, RS, Brazil
| | | | - Daniela Fernandes Ramos
- Núcleo de Pesquisa em Microbiologia Médica, Faculdade de Medicina, Universidade Federal do Rio Grande, FURG, Rio Grande, RS, Brazil
| | - Sibele Borsuk
- Laboratório de Biotecnologia Infecto-parasitária, Centro de Desenvolvimento Tecnológico, Biotecnologia, UFPel, Campus Universitário s/n, Prédio 19 -, Pelotas, RS, 96010-900, Brazil.
| |
Collapse
|
15
|
Volatile Secondary Metabolites with Potent Antidiabetic Activity from the Roots of Prangos pabularia Lindl.—Computational and Experimental Investigations. APPLIED SCIENCES-BASEL 2019. [DOI: 10.3390/app9112362] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
(1) Background: Almost 500 million people worldwide are suffering from diabetes. Since ancient times, humans have used medicinal plants for the treatment of diabetes. Medicinal plants continue to serve as natural sources for the discovery of antidiabetic compounds. Prangos pabularia Lindl. is a widely distributed herb with large reserves in Tajikistan. Its roots and fruits have been used in Tajik traditional medicine. To our best knowledge, there are no previously published reports concerning the antidiabetic activity and the chemical composition of the essential oil obtained from roots of P. pabularia. (2) Methods: The volatile secondary metabolites were obtained by hydrodistillation from the underground parts of P. pabularia growing wild in Tajikistan and were analyzed by gas chromatography (GC) and gas chromatography-mass spectrometry (GC-MS). Protein tyrosine phosphatase 1B (PTP-1B) inhibition assay and molecular docking analysis were carried out to evaluate the potential antidiabetic activity of the P. pabularia essential oil. (3) Results: The main constituents of the volatile oil of P. pabularia were 5-pentylcyclohexa-1,3-diene (44.6%), menthone (12.6%), 1-tridecyne (10.9%), and osthole (6.0%). PTP-1B inhibition assay of the essential oil and osthole resulted in significant inhibitory activity with an IC50 value of 0.06 ± 0.01 and 0.93 ± 0.1 μg/mL. Molecular docking analysis suggests volatile compounds such as osthole inhibit PTP-1B, and the results are also in agreement with experimental investigations. (4) Conclusions: Volatile secondary metabolites and the pure isolated compound (osthole) from the roots of P. pabularia exhibited potent antidiabetic activity, twenty-five and nearly two times more than the positive control (3-(3,5-dibromo-4-hydroxybenzoyl)-2-ethylbenzofuran-6-sulfonic acid-(4-(thiazol-2-ylsulfamyl)-phenyl)-amide)) with an IC50 value of 1.46 ± 0.4 μg/mL, respectively.
Collapse
|
16
|
Kulyashova LB, Roschina N, Nikitina TV, Soultanov VS. Anti-protozoal Activity of Conifer Green Needle Complex against Trichomonas vaginalis. Nat Prod Commun 2019. [DOI: 10.1177/1934578x1901400138] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
Treatment of Trichomonas vaginalis typically involves using nitroimidazoles (such as metronidazole and tinidazole). Some T. vaginalis strains have become resistant to these drugs, so the development of new drugs is necessary. Clinical samples were taken from 80 males and 70 females (aged 17–45). The sensitivity of T. vaginalis in these samples to CGNC (100, 200, 300 and 500 mg/mL) and metronidazole (10, 15, 25 and 50 μg/mL) was evaluated. All 10 isolates were sensitive to at least one concentration of CGNC. Three strains were sensitive (all cells were killed) to 100 mg/mL CGNC, while there was a decrease in the number of Trichomonas present in the other samples when compared with the control. Six strains were sensitive to 200 mg/mL CGNC, while those strains that grew in the presence of CGNC showed a reduction in numbers when compared with the control. Nine strains were sensitive to 300 mg/mL CGNC. The strain not sensitive to 300 mg/mL CGNC showed a decrease in the number of Trichomonas present (<102 cells/mL) when compared to the control (104 cells/mL). All strains were sensitive to 500 mg/mL CGNC. Three strains (one motile and two non-motile) were sensitive to all concentrations of CGNC and one of the non-motile strains was resistant (MIC 50 μg/mL) to metronidazole. The other two strains were moderately resistant (MIC 15 and 25 μg/mL) to metronidazole. Of the 10 Trichomonas strains, four were resistant to metronidazole (MIC 50 μg/mL) and sensitive to at least one concentration of CGNC. CGNC may be used as a treatment for T. vaginalis infections and should be considered for clinical strains resistant to metronidazole.
Collapse
Affiliation(s)
- Lidia B. Kulyashova
- The Pasteur Research Institute, Saint Petersburg 14, Mira Street, 197101, St. Petersburg, Russia
| | - Natalia Roschina
- The Pasteur Research Institute, Saint Petersburg 14, Mira Street, 197101, St. Petersburg, Russia
| | - Tamara V. Nikitina
- I.M. Sechenov Institute of Evolutionary Physiology and Biochemistry of the Russian Academy of Sciences, Saint Petersburg, pr. Torez 44, St Petersburg, 194223, St. Petersburg, Russia
| | - Vagif S. Soultanov
- Honorary Doctor, Saint Petersburg State Forest Technical University, 5 Institutskiy pereulok, 194021, St. Petersburg, Russia
- Prenolica Limited, 98–106, Moray St, South Melbourne, 3205, Australia
| |
Collapse
|
17
|
Carapina da Silva C, Pacheco BS, das Neves RN, Dié Alves MS, Sena-Lopes Â, Moura S, Borsuk S, de Pereira CMP. Antiparasitic activity of synthetic curcumin monocarbonyl analogues against Trichomonas vaginalis. Biomed Pharmacother 2018; 111:367-377. [PMID: 30594049 DOI: 10.1016/j.biopha.2018.12.058] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/15/2018] [Revised: 11/25/2018] [Accepted: 12/14/2018] [Indexed: 12/14/2022] Open
Abstract
Trichomoniasis is a parasitic infection caused by Trichomonas vaginalis and it is considered to be the most common non-viral sexually transmitted infection in the world. Since the 1960s, nitroimidazoles such as metronidazole are the drugs of choice for the treatment of trichomoniasis, but many adverse effects and allergic reactions may result from their use. Reports of metronidazole-resistant infections also highlight the importance for the search of new anti-T. vaginalis agents. Considering this, herein we report the anti-T. vaginalis evaluation of 21 synthetic monocarbonyl analogues of curcumin, which itself has been reported to possess antiparasitic potential. From the in vitro analysis of the synthetic molecules, untreated trophozoites, and metronidazole at 100 μM, it was observed that three curcumin analogues (3a, 3e, and 5e) exhibited anti-T. vaginalis activity comparable to metronidazole (no significant statistical difference). Optimal antiparasitic concentrations were determined to be 80 μM and 90 μM for propanone derivatives 3a and 3e, respectively, and 200 μM for cyclohexanone derivative 5e. Kinetic growth curves showed that, after 24 h, the trophozoites were completely inhibited. At the tested concentrations, natural curcumin did not significantly inhibit the growth of trophozoites, therefore demonstrating that the designed synthetic molecules not only have better chemical stability, but also higher anti-T. vaginalis potential. Cytotoxicity analysis, performed on VERO cells, demonstrated low, moderate and high cytotoxic effects for analogues 3e, 5e and 3a, respectively. This study suggests that these analogues possess chemical features of interest to be further explored as alternatives for the treatment of trichomoniasis.
Collapse
Affiliation(s)
- Caroline Carapina da Silva
- Laboratory of Lipidomics and Bioorganic, Bioforensics Research Group, Federal University of Pelotas, RS, 96010-900, Brazil.
| | - Bruna Silveira Pacheco
- Laboratory of Lipidomics and Bioorganic, Bioforensics Research Group, Federal University of Pelotas, RS, 96010-900, Brazil
| | | | - Mirna Samara Dié Alves
- Laboratory of Infecto-parasitic Biotechnology, Federal University of Pelotas, RS, 96010-900, Brazil
| | - Ângela Sena-Lopes
- Laboratory of Infecto-parasitic Biotechnology, Federal University of Pelotas, RS, 96010-900, Brazil
| | - Sidnei Moura
- Laboratory of Biotechnology of Natural and Synthetic Products, Biotechnology Institute, University of Caxias do Sul, RS, 95020260, Brazil
| | - Sibele Borsuk
- Laboratory of Infecto-parasitic Biotechnology, Federal University of Pelotas, RS, 96010-900, Brazil
| | | |
Collapse
|
18
|
Küng E, Fürnkranz U, Walochnik J. Chemotherapeutic options for the treatment of human trichomoniasis. Int J Antimicrob Agents 2018; 53:116-127. [PMID: 30612993 DOI: 10.1016/j.ijantimicag.2018.10.016] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/25/2018] [Revised: 10/11/2018] [Accepted: 10/20/2018] [Indexed: 01/08/2023]
Abstract
Trichomonas vaginalis is the causative agent of the most common non-viral sexually transmitted disease worldwide. The infection may be associated with severe complications, including infertility, preterm labour, cancer and an increased risk of human immunodeficiency virus (HIV) transmission. Treatment remains almost exclusively based on 5-nitroimidazoles, but resistance is on the rise. This article provides an overview of clinically evaluated systemic and topical treatment options for human trichomoniasis and summarises the current state of knowledge on various herbal, semisynthetic and synthetic compounds evaluated for their anti-Trichomonas efficacy in vitro.
Collapse
Affiliation(s)
- Erik Küng
- Institute of Specific Prophylaxis and Tropical Medicine, Centre for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Kinderspitalgasse 15, A-1090 Vienna, Austria
| | - Ursula Fürnkranz
- Institute of Specific Prophylaxis and Tropical Medicine, Centre for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Kinderspitalgasse 15, A-1090 Vienna, Austria
| | - Julia Walochnik
- Institute of Specific Prophylaxis and Tropical Medicine, Centre for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Kinderspitalgasse 15, A-1090 Vienna, Austria.
| |
Collapse
|
19
|
Budama-Kilinc Y, Cakir-Koc R, Kecel-Gunduz S, Zorlu T, Kokcu Y, Bicak B, Karavelioglu Z, Ozel AE. Papain Loaded Poly(ε-Caprolactone) Nanoparticles: In-silico and In-Vitro Studies. J Fluoresc 2018; 28:1127-1142. [PMID: 30097974 DOI: 10.1007/s10895-018-2276-6] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/25/2018] [Accepted: 07/30/2018] [Indexed: 01/24/2023]
Abstract
Papain is a protease enzyme with therapeutic properties that are very valuable for medical applications. Poly(ε-caprolactone) (PCL) is an ideal polymeric carrier for controlled drug delivery systems due to its low biodegradability and its high biocompatibility. In this study, the three-dimensional structure and action mechanism of papain were investigated by in vitro and in silico experiments using molecular dynamics (MD) and molecular docking methods to elucidate biological functions. The results showed that the size of papain-loaded PCL nanoparticles (NPs) and the polydispersity index (PDI) of the NPs were 242.9 nm and 0.074, respectively. The encapsulation efficiency and loading efficiency were 80.4 and 27.2%, respectively. Human embryonic kidney cells (HEK-293) were used for determining the cytotoxicity of papain-loaded PCL and PCL nanoparticles. The in vitro cell culture showed that nanoparticles are not toxic at low concentrations, while toxicity slightly increases at high concentrations. In silico studies, which were carried out with MD simulations and ADME analysis showed that the strong hydrogen bonds between the ligand and the papain provide stability and indicate the regions in which the interactions occur.
Collapse
Affiliation(s)
- Yasemin Budama-Kilinc
- Faculty of Chemical and Metallurgical Engineering, Department of Bioengineering, Yildiz Technical University, 34220, Istanbul, Turkey.
| | - Rabia Cakir-Koc
- Faculty of Chemical and Metallurgical Engineering, Department of Bioengineering, Yildiz Technical University, 34220, Istanbul, Turkey
| | - Serda Kecel-Gunduz
- Faculty of Science, Physics Department, Istanbul University, 34134, Istanbul, Turkey
| | - Tolga Zorlu
- Graduate School of Natural and Applied Science, Yildiz Technical University, 34220, Istanbul, Turkey
| | - Yagmur Kokcu
- Graduate School of Engineering and Sciences, Istanbul University, 34452, Istanbul, Turkey
| | - Bilge Bicak
- Faculty of Science, Physics Department, Istanbul University, 34134, Istanbul, Turkey
- Graduate School of Engineering and Sciences, Istanbul University, 34452, Istanbul, Turkey
| | - Zeynep Karavelioglu
- Graduate School of Natural and Applied Science, Yildiz Technical University, 34220, Istanbul, Turkey
| | - Aysen E Ozel
- Faculty of Science, Physics Department, Istanbul University, 34134, Istanbul, Turkey
| |
Collapse
|
20
|
Copaifera of the Neotropics: A Review of the Phytochemistry and Pharmacology. Int J Mol Sci 2018; 19:ijms19051511. [PMID: 29783680 PMCID: PMC5983702 DOI: 10.3390/ijms19051511] [Citation(s) in RCA: 51] [Impact Index Per Article: 8.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2018] [Revised: 05/15/2018] [Accepted: 05/15/2018] [Indexed: 12/25/2022] Open
Abstract
The oleoresin of Copaifera trees has been widely used as a traditional medicine in Neotropical regions for thousands of years and remains a popular treatment for a variety of ailments. The copaiba resins are generally composed of a volatile oil made up largely of sesquiterpene hydrocarbons, such as β-caryophyllene, α-copaene, β-elemene, α-humulene, and germacrene D. In addition, the oleoresin is also made up of several biologically active diterpene acids, including copalic acid, kaurenoic acid, alepterolic acid, and polyalthic acid. This review presents a summary of the ecology and distribution of Copaifera species, the traditional uses, the biological activities, and the phytochemistry of copaiba oleoresins. In addition, several biomolecular targets relevant to the bioactivities have been implicated by molecular docking methods.
Collapse
|
21
|
Lin D, Wang L, Yan Z, Ye J, Hu A, Liao H, Liu J, Peng J. Semi-synthesis, structural modification and biological evaluation of 5-arylbenzofuran neolignans. RSC Adv 2018; 8:34331-34342. [PMID: 35548655 PMCID: PMC9087020 DOI: 10.1039/c8ra04773a] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/04/2018] [Accepted: 10/01/2018] [Indexed: 01/11/2023] Open
Abstract
5-Arylbenzofuran neolignans, a newfound class of natural products, were semi-synthesized, and a series of derivatives were designed, synthesized and evaluated for cytotoxicity.
Collapse
Affiliation(s)
- Ding Lin
- College of Chemistry and Chemical Engineering
- Hunan University
- Changsha 410082
- China
| | - Long Wang
- College of Biology
- Hunan University
- Changsha 410082
- China
| | - Zhongzhong Yan
- College of Chemistry and Chemical Engineering
- Hunan University
- Changsha 410082
- China
| | - Jiao Ye
- College of Chemistry and Chemical Engineering
- Hunan University
- Changsha 410082
- China
| | - Aixi Hu
- College of Chemistry and Chemical Engineering
- Hunan University
- Changsha 410082
- China
| | - Hongdong Liao
- College of Biology
- Hunan University
- Changsha 410082
- China
| | - Juan Liu
- College of Pharmacy and Biological Science
- University of South China
- Hengyang 421000
- China
| | - Junmei Peng
- College of Pharmacy and Biological Science
- University of South China
- Hengyang 421000
- China
| |
Collapse
|
22
|
Noritake SM, Liu J, Kanetake S, Levin CE, Tam C, Cheng LW, Land KM, Friedman M. Phytochemical-rich foods inhibit the growth of pathogenic trichomonads. Altern Ther Health Med 2017; 17:461. [PMID: 28903731 PMCID: PMC5598040 DOI: 10.1186/s12906-017-1967-x] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/25/2017] [Accepted: 09/05/2017] [Indexed: 12/29/2022]
Abstract
Background Plants produce secondary metabolites that often possess widespread bioactivity, and are then known as phytochemicals. We previously determined that several phytochemical-rich food-derived preparations were active against pathogenic foodborne bacteria. Trichomonads produce disease (trichomoniasis) in humans and in certain animals. Trichomonads are increasingly becoming resistant to conventional modes of treatment. It is of interest to test bioactive, natural compounds for efficacy against these pathogens. Methods Using a cell assay, black tea, green tea, grape, pomegranate, and jujube extracts, as well as whole dried jujube were tested against three trichomonads: Trichomonas vaginalis strain G3 (found in humans), Tritrichomonas foetus strain D1 (found in cattle), and Tritrichomonas foetus-like organism strain C1 (found in cats). The most effective of the test substances was subsequently tested against two metronidazole-resistant Trichomonas vaginalis strains, and on normal mucosal flora. Results Black tea extract inhibited all the tested trichomonads, but was most effective against the T. vaginalis organisms. Inhibition by black tea was correlated with the total and individual theaflavin content of the two tea extracts determined by HPLC. Metronidazole-resistant Trichomonas vaginalis strains were also inhibited by the black tea extract. The response of the organisms to the remaining preparations was variable and unique. We observed no effect of the black tea extract on common normal flora bacteria. Conclusions The results suggest that the black tea, and to a lesser degree green tea, grape seed, and pomegranate extracts might present possible natural alternative therapeutic agents to treat Trichomonas vaginalis infections in humans and the related trichomonad infections in animals, without negatively affecting the normal flora.
Collapse
|